Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +12.4%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (494)

clinicaltrialsPublishedShowing 151–200 of 3,457 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02679144	Neuroblastoma Maintenance Therapy Trial(NMTT)	active not recruiting	Phase 2	441	Giselle ShollerOTHER	2	Sep 3, 2026	clinicaltrials
NCT03657576	Trial of C134 in Patients With Recurrent GBM(C134-HSV-1)	completed	Phase 1	19	University of Alabama at BirminghamOTHER	1	Sep 3, 2026	clinicaltrials